PURPOSE: To determine if quantitative changes in retinal pigment epithelial detachments (PEDs) predict the need for retreatment in eyes undergoing spectral domain optical coherence tomography (SD OCT)-guided as-needed therapy with anti-vascular endothelial growth factor drugs. METHODS: Patients with vascularized PEDs undergoing SD OCT-guided treatment with anti-vascular endothelial growth factor drugs were retrospectively identified. The decision to retreat these cases was based on qualitative assessments of fluid in the macula. Spectral domain OCT images from visits in which the treatment was withheld were retrospectively analyzed. A novel algorithm was then used to measure the area and volume of PEDs at these visits. RESULTS: Fourteen eyes were identified, and retreatment was withheld at 57 visits. When the SD OCT algorithm was used to evaluate the scans from these visits, the PED volume increased at eight visits. At all of these eight visits, a treatment was needed at the next follow-up visit. For the remaining 49 visits in which the treatment was withheld, the PED volume did not increase and no treatment was needed at the next follow-up visit. CONCLUSION: Quantitation of the change in the PED volume and area may be useful in determining when to retreat eyes undergoing SD OCT-guided as-needed anti-vascular endothelial growth factor therapy.
PURPOSE: To determine if quantitative changes in retinal pigment epithelial detachments (PEDs) predict the need for retreatment in eyes undergoing spectral domain optical coherence tomography (SD OCT)-guided as-needed therapy with anti-vascular endothelial growth factor drugs. METHODS:Patients with vascularized PEDs undergoing SD OCT-guided treatment with anti-vascular endothelial growth factor drugs were retrospectively identified. The decision to retreat these cases was based on qualitative assessments of fluid in the macula. Spectral domain OCT images from visits in which the treatment was withheld were retrospectively analyzed. A novel algorithm was then used to measure the area and volume of PEDs at these visits. RESULTS: Fourteen eyes were identified, and retreatment was withheld at 57 visits. When the SD OCT algorithm was used to evaluate the scans from these visits, the PED volume increased at eight visits. At all of these eight visits, a treatment was needed at the next follow-up visit. For the remaining 49 visits in which the treatment was withheld, the PED volume did not increase and no treatment was needed at the next follow-up visit. CONCLUSION: Quantitation of the change in the PED volume and area may be useful in determining when to retreat eyes undergoing SD OCT-guided as-needed anti-vascular endothelial growth factor therapy.
Authors: Justis P Ehlers; Robert Zahid; Peter K Kaiser; Jeffrey S Heier; David M Brown; Xiangyi Meng; Jamie Reese; Thuy K Le; Leina Lunasco; Ming Hu; Sunil K Srivastava Journal: Ophthalmol Retina Date: 2021-02-26
Authors: Xiaoshuang Jiang; Mengxi Shen; Liang Wang; Luis de Sisternes; Mary K Durbin; William Feuer; Philip J Rosenfeld; Giovanni Gregori Journal: Transl Vis Sci Technol Date: 2021-04-01 Impact factor: 3.283
Authors: Mengxi Shen; Hao Zhou; Kiyoung Kim; Qiyu Bo; Jie Lu; Rita Laiginhas; Xiaoshuang Jiang; Quan Yan; Prashanth Iyer; Omer Trivizki; Yingying Shi; Luis de Sisternes; Mary K Durbin; William Feuer; Giovanni Gregori; Ruikang K Wang; Xiaodong Sun; Fenghua Wang; Seung-Young Yu; Philip J Rosenfeld Journal: Invest Ophthalmol Vis Sci Date: 2021-12-01 Impact factor: 4.799
Authors: Maximilian W M Wintergerst; Thomas Schultz; Johannes Birtel; Alexander K Schuster; Norbert Pfeiffer; Steffen Schmitz-Valckenberg; Frank G Holz; Robert P Finger Journal: Transl Vis Sci Technol Date: 2017-07-18 Impact factor: 3.283
Authors: Gabriella Moraes; Dun Jack Fu; Marc Wilson; Hagar Khalid; Siegfried K Wagner; Edward Korot; Daniel Ferraz; Livia Faes; Christopher J Kelly; Terry Spitz; Praveen J Patel; Konstantinos Balaskas; Tiarnan D L Keenan; Pearse A Keane; Reena Chopra Journal: Ophthalmology Date: 2020-09-24 Impact factor: 12.079